Metraipolis › archive › dc_766af2ecabce
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models — Europe PMC PMID:38915782
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38915782
- DOI
- 10.1080/2162402x.2024.2370544
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T17:11:10.817Z
- SHA-256 of the archived text
1c68e813d66e85ccac518f429e14442382b473ddf916e39bc5ecd87e88591506- Stable URL of this page
https://metraipolis.com/documento/dc_766af2ecabce
How to cite
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models — Europe PMC PMID:38915782 — Europe PMC (en), https://europepmc.org/article/MED/38915782 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_766af2ecabce (Metraipolis archive dc_766af2ecabce, sha256 1c68e813d66e85ccac518f429e14442382b473ddf916e39bc5ecd87e88591506)
BibTeX
@misc{dc766af2ecabce,
title = {Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models — Europe PMC PMID:38915782},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38915782},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_766af2ecabce; sha256 1c68e813d66e85ccac518f429e14442382b473ddf916e39bc5ecd87e88591506},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38915782. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Regulatory T cells (Tregs) play a crucial role in mediating immunosuppression in the tumor microenvironment. Furthermore, Tregs contribute to the lack of efficacy and hyperprogressive disease upon Programmed cell death protein 1 (PD-1) blockade immunotherapy. Thus, Tregs are considered a promising therapeutic target, especially when combined with PD-1 blockade. However, systemic depletion of Tregs causes severe autoimmune adverse events, which poses a serious challenge to Treg-directed therapy. Here, we developed a novel treatment to locally and predominantly damage Tregs by near-infrared duocarmycin photorelease (NIR-DPR). In this technology, we prepared anti-CD25 F(ab') 2 conjugates, which site-specifically uncage duocarmycin in CD25-expressing cells upon exposure to NIR light. In vitro , CD25-targeted NIR-DPR significantly increased apoptosis of CD25-expressing HT2-A5E cells. When tumors were irradiated with NIR light in vivo , intratumoral CD25 + Treg populations decreased and Ki-67 and Interleukin-10 expression was suppressed, indicating impaired functioning of intratumoral CD25 + Tregs. CD25-targeted NIR-DPR suppressed tumor growth and improved survival in syngeneic murine tumor models. Of note, CD25-targeted NIR-DPR synergistically enhanced the efficacy of PD-1 blockade, especially in tumors with higher CD8 + /Treg PD-1 ratios. Furthermore, the combination therapy induced significant anti-cancer immunity including maturation of dendritic cells, extensive intratumoral infiltration of cytotoxic CD8 + T cells, and increased differentiation into CD8 + memory T cells. Altogether, CD25-targeted NIR-DPR locally and predominantly targets Tregs in the tumor microenvironment and synergistically improves the efficacy of PD-1 blockade, suggesting that this combination therapy can be a rational anti-cancer combination immunotherapy. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Oncoimmunology, 2024 (prima pubblicazione 2024-06-20). Identificativi: PMID 38915782 · PMCID PMC11195482 · DOI 10.1080/2162402x.2024.2370544. Parole chiave degli autori: regulatory T cell; Antibody-drug Conjugate; Near-infrared Light; Pd-1 Blockade; Photouncaging. Descrittori MeSH principali: T-Lymphocytes, Regulatory; Tumor Microenvironment; Programmed Cell Death 1 Receptor; Duocarmycins. Pagina: https://europepmc.org/article/MED/38915782 — https://doi.org/10.1080/2162402x.2024.2370544. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T15:36:03.104Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.